Lastly, in the latest criteria14 for diagnosis and staging of Alzheimer's disease, the biomarker framework was updated to the ATX system (amyloid, tau, neurodegeneration, inflammation, vascular and α-synuclein), however, only amyloid, tau and neurodegeneration were discussed in this study. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.